Works matching IS 00071048 AND DT 2021 AND VI 192 AND IP 6

Results: 33
    1

    Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1054, doi. 10.1111/bjh.17347
    By:
    • Loghavi, Sanam;
    • DiNardo, Courtney D.;
    • Furudate, Ken;
    • Takahashi, Koichi;
    • Tanaka, Tomoyuki;
    • Short, Nicholas J.;
    • Kadia, Tapan;
    • Konopleva, Marina;
    • Kanagal‐Shamanna, Rashmi;
    • Farnoud, Noushin R.;
    • Pierce, Sherry;
    • Khoury, Joseph D.;
    • Jorgensen, Jeffrey L.;
    • Patel, Keyur P.;
    • Daver, Naval;
    • Yilmaz, Musa;
    • Medeiros, L. Jeffrey;
    • Kantarjian, Hagop;
    • Ravandi, Farhad;
    • Wang, Sa A.
    Publication type:
    Article
    2
    3

    Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. e148, doi. 10.1111/bjh.17365
    By:
    • Schliemann, Christoph;
    • Kessler, Torsten;
    • Berdel, Andrew F.;
    • Hemmerle, Teresa;
    • Angenendt, Linus;
    • Altvater, Bianca;
    • Rossig, Claudia;
    • Mikesch, Jan‐Henrik;
    • Lenz, Georg;
    • Schäfers, Michael;
    • Neri, Dario;
    • Stelljes, Matthias;
    • Berdel, Wolfgang E.
    Publication type:
    Article
    4

    Cognitive performance as a predictor of healthcare transition in sickle cell disease.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1082, doi. 10.1111/bjh.17351
    By:
    • Saulsberry‐Abate, Anjelica C.;
    • Partanen, Marita;
    • Porter, Jerlym S.;
    • Podila, Pradeep S. B.;
    • Hodges, Jason R.;
    • King, Allison A.;
    • Wang, Winfred C.;
    • Schreiber, Jane E.;
    • Zhao, Xiwen;
    • Kang, Guolian;
    • Jacola, Lisa M.;
    • Hankins, Jane S.
    Publication type:
    Article
    5
    6
    7

    Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1100, doi. 10.1111/bjh.17266
    By:
    • Betrains, Albrecht;
    • Godinas, Laurent;
    • Woei‐A‐Jin, F. J. Sherida H.;
    • Rosseels, Wouter;
    • Van Herck, Yannick;
    • Lorent, Natalie;
    • Dierickx, Daan;
    • Compernolle, Veerle;
    • Meyfroidt, Geert;
    • Vanderbeke, Lore;
    • Vergote, Valentijn;
    • Lagrou, Katrien;
    • Verhamme, Peter;
    • Wauters, Joost;
    • Vermeersch, Pieter;
    • Devos, Timothy;
    • Maes, Piet;
    • Vanderschueren, Steven
    Publication type:
    Article
    8

    Rearrangements of ATP5L‐KMT2A in acute lymphoblastic leukaemia.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. e139, doi. 10.1111/bjh.17265
    By:
    • Ferrari, Anna;
    • Ghelli Luserna Di Rora, Andrea;
    • Domizio, Chiara;
    • Papayannidis, Cristina;
    • Simonetti, Giorgia;
    • Maria Hernández‐Rivas, Jesus;
    • Rondoni, Michela;
    • Giglio, Fabio;
    • Abruzzese, Elisabetta;
    • Imovilli, Annalisa;
    • Iacobucci, Ilaria;
    • Calistri, Daniele;
    • Martinelli, Giovanni
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Corrigendum.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1106, doi. 10.1111/bjh.17114
    Publication type:
    Article
    15

    Paradoxical effect of SARS‐CoV‐2 infection in patients with immune thrombocytopenia.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 973, doi. 10.1111/bjh.17077
    By:
    • Cruz‐Benito, Beatriz;
    • Rivas‐Pollmar, María I.;
    • Álvarez Román, María T.;
    • Trelles‐Martínez, Roberto;
    • Martín‐Salces, Monica;
    • Lázaro‐del Campo, Paula;
    • Ramírez‐López, Andrés;
    • García‐Barcenilla, Sara;
    • Cebanu, Tamara;
    • Acuña‐Butta, Paula;
    • Monzón‐Manzano, Elena;
    • González‐Zorrilla, Elena;
    • Jiménez‐Yuste, Victor;
    • Butta, Nora V.
    Publication type:
    Article
    16

    The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 978, doi. 10.1111/bjh.17062
    By:
    • Diamantopoulos, Panagiotis T.;
    • Symeonidis, Argiris;
    • Pappa, Vasiliki;
    • Kotsianidis, Ioannis;
    • Galanopoulos, Athanasios;
    • Pontikoglou, Charalampos;
    • Anagnostopoulos, Achilles;
    • Vassilopoulos, George;
    • Zikos, Panagiotis;
    • Hatzimichael, Eleftheria;
    • Papaioannou, Maria;
    • Megalakaki, Aekaterini;
    • Repousis, Panagiotis;
    • Kotsopoulou, Maria;
    • Dimou, Maria;
    • Solomou, Elena;
    • Dryllis, Georgios;
    • Tsokanas, Dimitrios;
    • Papoutselis, Menelaos‐Konstantinos;
    • Papageorgiou, Sotirios
    Publication type:
    Article
    17
    18
    19

    Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 988, doi. 10.1111/bjh.16988
    By:
    • Alvarez‐Larrán, Alberto;
    • Angona, Anna;
    • Andrade‐Campos, Marcio;
    • Soledad Noya, M.;
    • Teresa Gómez‐Casares, M.;
    • Cuevas, Beatriz;
    • Caballero, Gonzalo;
    • García‐Hernández, Carmen;
    • García‐Gutiérrez, Valentín;
    • Palomino, Alicia;
    • Ferrer‐Marín, Francisca;
    • Isabel Mata‐Vázquez, M.;
    • Moretó, Ana;
    • Magro, Elena;
    • Murillo, Ilda;
    • Manuel Alonso‐Domínguez, Juan;
    • María Guerra, José;
    • Guerrero, Lucía;
    • María Raya, José;
    • Pérez‐Encinas, Manuel
    Publication type:
    Article
    20
    21

    In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1068, doi. 10.1111/bjh.16865
    By:
    • Rigolin, Gian Matteo;
    • Saccenti, Elena;
    • Melandri, Aurora;
    • Cavallari, Maurizio;
    • Urso, Antonio;
    • Rotondo, Francesco;
    • Betulla, Anita;
    • Tognolo, Lucia;
    • Bardi, Maria Antonella;
    • Rossini, Marika;
    • Tammiso, Elisa;
    • Bassi, Christian;
    • Cavazzini, Francesco;
    • Negrini, Massimo;
    • Cuneo, Antonio
    Publication type:
    Article
    22

    Issue Information.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 943, doi. 10.1111/bjh.16826
    Publication type:
    Article
    23
    24
    25
    26

    Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1026, doi. 10.1111/bjh.16722
    By:
    • Tiong, Ing S.;
    • Dillon, Richard;
    • Ivey, Adam;
    • Teh, Tse‐Chieh;
    • Nguyen, Phillip;
    • Cummings, Nicholas;
    • Taussig, David C.;
    • Latif, Annie‐Louise;
    • Potter, Nicola E.;
    • Runglall, Manohursingh;
    • Russell, Nigel H.;
    • Raj, Kavita;
    • Schwarer, Anthony P.;
    • Fong, Chun Yew;
    • Grigg, Andrew P.;
    • Wei, Andrew H.
    Publication type:
    Article
    27
    28
    29

    Prognostic indices in diffuse large B‐cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R‐CHOP 14 versus 21 phase 3 trial.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1015, doi. 10.1111/bjh.16691
    By:
    • Gleeson, Mary;
    • Counsell, Nicholas;
    • Cunningham, David;
    • Lawrie, Anthony;
    • Clifton‐Hadley, Laura;
    • Hawkes, Eliza;
    • McMillan, Andrew;
    • Ardeshna, Kirit M.;
    • Burton, Cathy;
    • Chadwick, Nick;
    • Gambell, Joanna;
    • Smith, Paul;
    • Mouncey, Paul;
    • Pocock, Christopher;
    • Radford, John;
    • Davies, John;
    • Turner, Deborah;
    • Kruger, Anton;
    • Johnson, Peter;
    • Linch, David
    Publication type:
    Article
    30

    The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1092, doi. 10.1111/bjh.16724
    By:
    • Al‐Samkari, Hanny;
    • Addonizio, Kathryn;
    • Glader, Bertil;
    • Morton, D. Holmes;
    • Chonat, Satheesh;
    • Thompson, Alexis A.;
    • Kuo, Kevin H. M.;
    • Ravindranath, Yaddanapudi;
    • Wang, Heng;
    • Rothman, Jennifer A.;
    • Kwiatkowski, Janet L.;
    • Kung, Charles;
    • Kosinski, Penelope A.;
    • Al‐Sayegh, Hasan;
    • London, Wendy B.;
    • Grace, Rachael F.
    Publication type:
    Article
    31
    32
    33

    Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1011, doi. 10.1111/bjh.16714
    By:
    • Massaro, Fulvio;
    • Stepanishyna, Yana;
    • Manni, Martina;
    • Luminari, Stefano;
    • Galimberti, Sara;
    • Marcheselli, Luigi;
    • Visco, Carlo;
    • Tecchio, Cristina;
    • Stelitano, Caterina;
    • Angrilli, Francesco;
    • Petrini, Mario;
    • Merli, Francesco;
    • Federico, Massimo
    Publication type:
    Article